Close Menu

Sandra Porter says that she was content to avoid microarrays for a long while, with the articles questioning reliability and stories coming out of labs. However, she's had a change of heart. "Then Next Generation DNA Sequencing (NGS) came along. It turned out that many of the data analysis techniques developed for microarrays were useful for analyzing Next Gen data. I couldn't avoid them anymore," Porter writes. "It was time to bite the bullet and learn about microarrays."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.